In an afebrile, hemodynamically stable man with acute urinary retention secondary to benign prostatic hyperplasia and mild hydronephrosis, whose urine analysis shows numerous pus cells and a positive nitrite test, what is the appropriate antibiotic therapy and overall management?

Management of Complicated UTI in a Man with BPH and Acute Urinary Retention

This patient requires immediate urethral or suprapubic catheterization for bladder decompression, followed by empirical intravenous antibiotic therapy with either a third-generation cephalosporin (ceftriaxone 1-2g daily) or a combination of amoxicillin plus an aminoglycoside, along with alpha-blocker therapy (alfuzosin 10mg, tamsulosin 0.4mg, or silodosin 8mg) to optimize trial without catheter success.

Classification and Risk Assessment

This presentation represents a complicated urinary tract infection (cUTI) based on multiple factors 1:

• Male gender - automatically classifies as complicated 1
• Urinary tract obstruction - acute retention with BPH 1
• Incomplete voiding - evidenced by retention 1
• Mild hydronephrosis - upper tract involvement 1

The presence of pyuria and positive nitrite confirms active bacterial infection requiring treatment 1. Despite being afebrile and hemodynamically stable, the obstructive component with hydronephrosis places this patient at risk for progression to urosepsis if not managed appropriately 1.

Immediate Management: Bladder Decompression

Catheterization Strategy

Perform immediate bladder catheterization - either urethral or suprapubic based on contraindications 2, 3:

• Urethral catheterization is the first-line approach (used in 82.7-89.8% of cases) 4, 5
• Suprapubic catheterization may offer superior patient comfort and reduced colonization rates, particularly if prolonged catheterization is anticipated 2
• Clean intermittent self-catheterization represents an alternative with improved quality of life for chronic management 2, 3

Critical pitfall: Avoid prolonged catheterization beyond 3-5 days, as this increases morbidity, adverse events, and hospitalization duration without improving trial without catheter (TWOC) success rates 4, 5.

Antibiotic Therapy

Empirical Regimen Selection

Initiate intravenous empirical antibiotics immediately given the complicated nature with obstruction and hydronephrosis 1:

Recommended first-line options 1:

• Amoxicillin plus aminoglycoside (gentamicin 5 mg/kg daily or amikacin 15 mg/kg daily)
• Second-generation cephalosporin plus aminoglycoside
• Third-generation cephalosporin monotherapy (ceftriaxone 1-2g daily or cefotaxime 2g three times daily)

Avoid fluoroquinolones for empirical treatment in this urology patient population, as resistance rates are typically >10% in men from urology departments 1. Fluoroquinolones should only be used if local resistance is <10% and the patient has not used them in the last 6 months 1.

Antibiotic Duration

Treat for 7-14 days depending on clinical response 1:

• 7 days may be sufficient if the patient remains hemodynamically stable and afebrile for at least 48 hours after relief of obstruction 1
• 14 days is recommended for men when prostatitis cannot be excluded 1
• Duration should be closely related to treatment of the underlying urological abnormality 1

Culture-Directed Therapy

Obtain urine culture and antimicrobial susceptibility testing before starting antibiotics 1. The microbial spectrum in complicated UTIs is broader than uncomplicated infections, with E. coli, Proteus spp., Klebsiella spp., Pseudomonas spp., Serratia spp., and Enterococcus spp. being most common 1. Tailor therapy once culture results are available 1.

Alpha-Blocker Therapy

Start an alpha-blocker immediately at catheterization to optimize TWOC success 2, 4, 5:

Recommended agents and dosing 2:

• Alfuzosin 10mg daily
• Tamsulosin 0.4mg daily
• Silodosin 8mg daily

Evidence supporting this approach: Alpha-blockers administered for 2-3 days before TWOC significantly improve success rates, with no single agent demonstrating superiority 2. In the French survey of 2,618 men, alpha-blocker use before TWOC increased success rates from 39.6% to 53.0% (P<0.001) 5. The worldwide survey of 6,074 men confirmed that alpha-blockers doubled the chances of TWOC success (OR 1.92,95% CI 1.52-2.42, P<0.001) 4.

Trial Without Catheter (TWOC)

Plan TWOC after 2-5 days of catheterization once the infection is controlled 2, 4, 5:

• Optimal timing: 3 days appears ideal, balancing success rates against complication risks 4, 5
• Expected success rate: Approximately 50-61% overall, higher with alpha-blocker use 4, 5

Predictors of TWOC failure to counsel the patient 4:

• Age ≥70 years
• Prostate size ≥50g
• Drained volume at catheterization ≥1000 mL
• Spontaneous (vs. precipitated) acute urinary retention

If TWOC fails: Consider a second TWOC (success rate ~26-30%) or proceed to elective surgery 4, 5. Recurrent or persistent UTI in men with BPH is an indication for surgical treatment 6.

Imaging and Further Evaluation

Upper urinary tract imaging is already completed (showing mild hydronephrosis), which is appropriate for ruling out obstruction and complications 1. If the patient remains febrile after 72 hours of treatment or clinically deteriorates, obtain contrast-enhanced CT scan immediately to assess for complications such as abscess or worsening obstruction 1.

Management of the Underlying Urological Abnormality

Appropriate management of BPH is mandatory for successful cUTI treatment 1. The acute retention with infection requires:

1. Immediate: Catheterization + antibiotics + alpha-blocker as outlined above
2. Short-term: TWOC after 2-5 days with continued alpha-blocker
3. Long-term: If TWOC fails or recurrent UTIs occur, surgical intervention (TURP or alternative procedure) should be considered 6

Important consideration: Asymptomatic bacteriuria should be screened for and treated before any surgical intervention such as TURP 6.